Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7808-13. doi: 10.1073/pnas.1104991108. Epub 2011 Apr 25.

2.

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.

Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14902-7. doi: 10.1073/pnas.1108892108. Epub 2011 Jul 11.

3.

Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.

Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E.

J Virol. 2015 Dec 30;90(6):2906-19. doi: 10.1128/JVI.02737-15.

4.

Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, Kieff E.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18537-42. doi: 10.1073/pnas.1317608110. Epub 2013 Oct 28.

5.

Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.

Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):554-9. doi: 10.1073/pnas.1422580112. Epub 2014 Dec 24.

6.

The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).

Gross H, Barth S, Pfuhl T, Willnecker V, Spurk A, Gurtsevitch V, Sauter M, Hu B, Noessner E, Mueller-Lantzsch N, Kremmer E, Grässer FA.

Int J Cancer. 2011 Sep 1;129(5):1105-15. doi: 10.1002/ijc.25760. Epub 2011 Jan 12.

7.

Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.

Peng CW, Xue Y, Zhao B, Johannsen E, Kieff E, Harada S.

Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):1033-8. Epub 2004 Jan 19.

8.

Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.

Peng CW, Zhao B, Chen HC, Chou ML, Lai CY, Lin SZ, Hsu HY, Kieff E.

Blood. 2007 Jun 15;109(12):5447-54. Epub 2007 Mar 6.

10.

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.

J Virol. 1990 Mar;64(3):1002-13.

11.

Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.

Pegman PM, Smith SM, D'Souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gélinas C, Walls D.

J Virol. 2006 Aug;80(16):8133-44.

12.

Four EBNA2 domains are important for EBNALP coactivation.

Peng CW, Zhao B, Kieff E.

J Virol. 2004 Oct;78(20):11439-42.

13.

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.

Rowe M, Raithatha S, Shannon-Lowe C.

J Virol. 2014 Oct;88(20):12065-76. doi: 10.1128/JVI.01431-14. Epub 2014 Aug 13.

14.

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

Strobl LJ, Höfelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U.

J Virol. 2000 Feb;74(4):1727-35.

15.

Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.

Fuentes-Pananá EM, Peng R, Brewer G, Tan J, Ling PD.

J Virol. 2000 Sep;74(17):8166-75.

16.

Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.

Portal D, Rosendorff A, Kieff E.

Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19278-83. Epub 2006 Dec 11.

17.

Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9.

Harth-Hertle ML, Scholz BA, Erhard F, Glaser LV, Dölken L, Zimmer R, Kempkes B.

PLoS Pathog. 2013 Sep;9(9):e1003638. doi: 10.1371/journal.ppat.1003638. Epub 2013 Sep 19.

18.

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

Henkel T, Ling PD, Hayward SD, Peterson MG.

Science. 1994 Jul 1;265(5168):92-5.

PMID:
8016657
19.

The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.

Liu CD, Chen YL, Min YL, Zhao B, Cheng CP, Kang MS, Chiu SJ, Kieff E, Peng CW.

PLoS Pathog. 2012;8(12):e1003084. doi: 10.1371/journal.ppat.1003084. Epub 2012 Dec 13.

20.

Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.

Gross H, Hennard C, Masouris I, Cassel C, Barth S, Stober-Grässer U, Mamiani A, Moritz B, Ostareck D, Ostareck-Lederer A, Neuenkirchen N, Fischer U, Deng W, Leonhardt H, Noessner E, Kremmer E, Grässer FA.

PLoS One. 2012;7(8):e42106. doi: 10.1371/journal.pone.0042106. Epub 2012 Aug 3.

Supplemental Content

Support Center